Cite
HARVARD Citation
Mehta, N. et al. (2019). Alpha‐Fetoprotein Decrease from > 1, 000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology. 69 (3), pp. 1193-1205. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mehta, N. et al. (2019). Alpha‐Fetoprotein Decrease from > 1, 000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology. 69 (3), pp. 1193-1205. [Online].